Johnson & Johnson vs. Lantern Pharma Inc. Common Stock
Johnson & Johnson and Lantern Pharma Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.
Size & Scale
| JNJ | LTRN | |
|---|---|---|
| Market Cap | $609.54 billion | $12.85 million |
| Revenue (TTM) | $97.93 billion | — |
| Net Income (TTM) | $21.04 billion | $-18,652,935 |
JNJ leads on 3 of 3 size & scale factors.
Valuation
| JNJ | LTRN | |
|---|---|---|
| P/E Ratio | 29.56 | — |
| Price / Book | 7.17 | -3.99 |
| Price / Sales | 6.22 | — |
LTRN leads on 1 of 1 valuation factors.
Profitability
| JNJ | LTRN | |
|---|---|---|
| Net Margin | 21.48% | — |
| Return on Equity | 24.76% | 579.78% |
LTRN leads on 1 of 1 profitability factors.
Dividend
| JNJ | LTRN | |
|---|---|---|
| Dividend Yield | 2.10% | — |
| Payout Ratio | 62.18 | — |
JNJ and LTRN split the dividend factors evenly.
Risk & Sentiment
| JNJ | LTRN | |
|---|---|---|
| Short Interest | 0.67% | 0.21% |
LTRN leads on 1 of 1 risk & sentiment factors.
Dig deeper: JNJ overview, JNJ financials, LTRN overview, LTRN financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.